SPOM Stock Overview
Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SPO Global Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0014 |
| 52 Week High | US$0.008 |
| 52 Week Low | US$0.001 |
| Beta | 0 |
| 1 Month Change | 27.27% |
| 3 Month Change | -36.36% |
| 1 Year Change | -78.46% |
| 3 Year Change | -97.36% |
| 5 Year Change | n/a |
| Change since IPO | -99.65% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SPOM | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 7.7% | 1.3% | 0.7% |
| 1Y | -78.5% | -6.8% | 23.9% |
Return vs Industry: SPOM underperformed the US Healthcare Services industry which returned -6.5% over the past year.
Return vs Market: SPOM underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| SPOM volatility | |
|---|---|
| SPOM Average Weekly Movement | 39.5% |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SPOM's share price has been volatile over the past 3 months.
Volatility Over Time: SPOM's weekly volatility has increased from 30% to 40% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Fengyou Lu | www.gerpanghealthcare.com |
Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics. The company was founded in 2006 and is based in Jinan, China.
SPO Global Inc. Fundamentals Summary
| SPOM fundamental statistics | |
|---|---|
| Market cap | US$606.16k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SPOM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SPOM income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SPOM perform over the long term?
See historical performance and comparison